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Introduction
Thrombocytopenia is a common laboratory finding among
critically ill patients. Studies have shown that thrombocy-
topenia is associated with increased morbidity and mortal-
ity, however there is limited evidence showing increasing
mortality with increasing severity of thrombocytopenia.
Several risk factors, such as sepsis and surgery, have been
associated with thrombocytopenia. The relationship
between routine coagulation parameters and platelet
count has not been explored.
Methods
This retrospective study included Intensive Care Unit
(ICU) patients admitted to the Royal Liverpool Univer-
sity Hospital between January 2008- January 2012.
Demographic details were collected at admission along
with routine blood results for the first 7 days. Thrombo-
cytopenia was categorised according to severity (severe
< 50 × 109/L, moderate 50-100 × 109/L, mild 100-150 ×
109/L during the first 7 days of ICU stay). The signifi-
cance of differences between groups was analysed using
one-way ANOVA for normally distributed data, Krus-
kal-Wallis test for non-parametric data and chi-squared
test for all categorical variables. Kaplan-Meier analysis
was performed to show the survival within different
categories of thrombocytopenia. Spearman’s correlation
was used to analyse the correlation between markers of
coagulation activation with platelets counts on admis-
sion to ICU.
Results
762 patients were included in the study; 162 mildly, 131
moderately and 111 severely thrombocytopenic patients
were identified. The 28-day mortality was significantly
higher in severely thrombocytopenic patients (30% vs 14%,
p < 0.001) compared to non-thrombocytopenic patients.
Platelet count dropped in all patients within the first two
to five days of critical illness, followed by a compensatory
increase in platelet numbers. In severely thrombocytope-
nic patients the platelet count continued to fall over five
days and was followed by slow improvement. Severely
thrombocytopenic patients had a significantly worse out-
come and a longer ICU stay compared to any other cate-
gory of thrombocytopenia. Persistent thrombocytopenia
over seven days was associated with mortality. There is no
correlation between routine coagulation values and plate-
lets at admission.
Conclusions
Severely thrombocytopenic patients had an increased mor-
bidity and mortality in this large cohort study. They took
longer for improvement in platelet count and are linked
with poor outcomes. Persistent thrombocytopenia is also
associated with mortality. Clinicians should be more vigi-
lant with this cohort and should promptly focus on causes
of thrombocytopenia in order to guide treatment.
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